Reports for TEVA-IRBESARTAN HCTZ
Brand name
TEVA-IRBESARTAN HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02330539 |
Ingredients
HYDROCHLOROTHIAZIDE IRBESARTAN |
Ingredient Strength
25 MG 300 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2017-08-01 | 2017-09-19 | 17839 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2019-10-24 | 2019-11-28 | 97153 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2020-04-10 | 2021-03-04 | 111865 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2020-07-14 | 2020-07-15 | 120235 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2020-09-22 | 2021-03-04 | 124743 |
| TEVA-IRBESARTAN HCTZ | 100 | Actual shortage | 2021-03-11 | 2021-03-11 | 135555 |
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|